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Cholesteryl ester accumulation by macrophages is
a critical early event in atherogenesis. To test the
hypothesis that sterol loading promotes foam cell
formation and vascular disease by perturbing a
network of interacting proteins, we used a global
approach to identify proteins that aredifferentially ex-
pressed when macrophages are loaded with choles-
terol in vivo. Our analysis revealed a sterol-respon-
sive network that is highly enriched in proteins with
known physical interactions, established roles in
vesicular transport, and demonstrated atheroscle-
rotic phenotypes in mice. Pharmacologic interven-
tionwith a statin or rosiglitazone and use ofmice defi-
cient in LDL receptor or apolipoprotein E implicated
the network in atherosclerosis. Biochemical fraction-
ation revealed that most of the sterol-responsive
proteins resided in microvesicles, providing a phys-
ical basis for the network’s functional and biochem-
ical properties. These observations identify a highly
integrated network of proteins whose expression is
influencedbyenvironmental, genetic, andpharmaco-
logical factors implicated in atherogenesis.
INTRODUCTION
Macrophages are essential effectors of innate and adaptive
immunity (Gordon and Taylor, 2005). Via their scavenger recep-
tors and other mechanisms, they clear bacterial pathogens and
apoptotic cells (Suzuki et al., 1997) and release a wide range of
cytokines and chemokines that orchestrate inflammation.
Recent studies have also implicated macrophages in tumor
progression, adipose tissue expansion, and insulin resistance
(de Luca and Olefsky, 2008; Wellen and Hotamisligil, 2005).
Moreover, these cells promote atherosclerosis by mediating
the uptake of modified lipoproteins into the artery wall (Li and
Glass, 2002).
When macrophages take up and degrade more lipoprotein-
derived cholesterol than they excrete, they convert free choles-
terol to cholesteryl ester, which accumulates as cytosolic lipid
droplets that appear foamy under the light microscope (Brown
and Goldstein, 1983). Genetic, biochemical, and clinical studiesCell Mprovide compelling evidence that macrophage foam cells are of
central importance in atherogenesis (Li and Glass, 2002).
One key source of this excess sterol in humans is low-density
lipoprotein (LDL). Moreover, mice with targeted disruption of the
LDL receptor gene (Ldlr) have markedly elevated LDL levels
when fed a western-type diet rich in cholesterol and saturated
fat (though mice normally have low levels of LDL and are resis-
tant to atherogenesis). Consequently, Ldlr/ mice rapidly
develop atherosclerosis (Ishibashi et al., 1994).
Because macrophages are key players in atherosclerosis and
many other conditions, it is likely that broad networks of interact-
ing genes and proteins (Ghazalpour et al., 2004; Schadt and
Lum, 2006; Lusis et al., 2008)—rather than simple linear path-
ways that affect only sterol balance—promote foam cell forma-
tion and atherogenesis. We therefore combined proteomics
with bioinformatics to obtain a global view ofmacrophages’ roles
in vascular disease. This approach uncovered a network of
proteins that is regulated when macrophages become foam
cells. Dietary studies, pharmacological interventions, and work
with genetically engineered mice linked this highly intercon-
nected sterol-responsive network to atherosclerosis.RESULTS
Identification of Macrophage Sterol-Responsive
Proteins
Previous studies have demonstrated that peritoneal macro-
phages of Ldlr/ mice can be loaded with cholesteryl ester
in vivo and that this model is relevant for studying the roles of
foam cells in atherosclerosis (Li et al., 2004).We therefore placed
Ldlr/mice on a chow (low-fat) or western-type (high-fat) diet for
14 weeks (Figure 1A) and then harvested macrophages from the
peritoneal cavity. Compared with control cells, macrophages
isolated from the mice on the western diet had markedly higher
levels of cellular cholesteryl ester mass (Figure 1B), the biochem-
ical hallmark of foam cells (Brown and Goldstein, 1986). Oil red
O staining and light microscopy confirmed that these macro-
phages were loaded with neutral lipid (Figures 1C and 1D).
We used LC-ESI-MS/MS analysis to identify 777 proteins with
high confidence in the medium of control and/or sterol-loaded
macrophages (Table S1 available online). To determine which
of those proteins changed their relative abundance whenmacro-
phages were sterol loaded in vivo, we used the G-test and t test
to find significant differences in spectral counts (Fu et al., 2008;
Liu et al., 2004; Old et al., 2005), a measure of relative proteinetabolism 11, 125–135, February 3, 2010 ª2010 Elsevier Inc. 125
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Figure 1. Proteomics Analysis of Conditioned Medium Harvested from Control and Sterol-Loaded Macrophages
Macrophages were isolated from the peritoneum of male Ldlr/ mice fed a chow (low-fat) or western (high-fat) diet for 14 weeks.
(A) Plasma cholesterol levels.
(B) Macrophage (Mf) cholesterol levels. FC, free cholesterol; CE, cholesteryl ester.
(C and D) Oil red O staining of macrophages.
(E) Medium conditioned bymacrophages isolated frommice fed a chow or western diet was digestedwith trypsin and analyzed by LC-ESI-MS/MS. Proteins were
quantified by the total number of unique peptides (spectral counts) detected by MS/MS. Confidence intervals (dotted lines; G > 1.5 and a = 0.04) and the FDR
were established by permutation analysis. Proteins differing in relative abundance between control and foam cells (blue d) were identified as those that exhibited
a significant difference in the total number of peptides, as assessed by both the t test (p value) and G-test (G-test).
(F) Representative example of a randomly selected permutation analysis (false positive result, blue d).
(G) Biochemical validation of differential protein expression by macrophage foam cells. Equal amounts of protein from medium conditioned by control cells or
foam cells were subjected to SDS-PAGE, using 4%–12%gradient gels. Proteins were transferred to PVDFmembranes and probedwith antibodies raised against
murine CYSC, APOE, C3, VIM, ACTB, LRP1, or ADFP.
Immunoblots were quantified by densitometry, and statistical significance was assessed using a two-tailed Student’s t test. Results are means and standard
deviations. See also Table S1.
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A Macrophage Sterol-Responsive Networkconcentration (Figure 1E). We estimated the false discovery rate
(FDR) by using the same statistical tests with all possible permu-
tations of the data. Permutation analysis revealed that G > 1.5
(G-test) and p < 0.04 (t test) yielded themost true-positive protein
identifications, with an estimated FDR of 6.3% (data not shown).
Using these stringent statistical criteria (Figure 1E), we identified
46 proteins that were expressed at a different level in medium of
macrophage foam cells than in medium of control cells isolated
from Ldlr/ mice fed a chow diet (Figure 2 and Table S1). In
contrast, only two proteins resided in this region of the graph
in a representative random permutation analysis (Figure 1F),
which is consistent with our estimated FDR.
We assessed the effectiveness of our analytical strategy by
using commercially available antibodies to quantify the relative
abundance of 7 of the 46 macrophage proteins that met our
statistical criteria: apolipoprotein E (APOE), cystatin C (CYSC),
complement factor C3 (C3), vimentin (VIM), b-actin (ACTB),
LDL receptor-related protein 1 (LRP1), and adipophilin (ADFP).
Immunoblot analysis of conditionedmedia of control and choles-
teryl ester-loaded macrophages (Figure 1G) verified significant
differences in the levels of all seven proteins (two-tailed126 Cell Metabolism 11, 125–135, February 3, 2010 ª2010 Elsevier InStudent’s t test: APOE, p = 0.001; CYSC, p = 0.002; C3,
p = 0.001; VIM, p = 0.008; ACTB, p = 0.0006; LRP1, p = 0.03;
ADFP, p = 0.02).
Differentially Expressed Proteins Form a Network
We call the 46 proteins that are differentially expressed by foam
cells ‘‘sterol responsive’’ because their relative abundance
changes significantly when Ldlr/ macrophages become
loaded with cholesteryl ester in vivo. We assessed the potential
functional significance of these proteins in three ways. First, we
searched for known physical interactions among them, using
Ingenuity systems (Calvano et al., 2005) and the BIND, DIP,
MIPS, IntAct, BioGRID, and MINT databases. These analyses
revealed a protein-protein interaction network of 26 proteins
(nodes) and 30 interactions (edges) (Figure 3), predictingmultiple
interactions among many of the 46 sterol-responsive proteins.
Second, we used Gene Ontology annotations to organize the
46 proteins into functional modules (Figure 3). This approach
identified significant enrichment (relative to the entire mouse
genome) in three modules: cytoskeletal regulation (p = 0.001),
vesicle-mediated transport (p = 0.003), and lipid bindingc.
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Figure 2. Proteins Differentially Expressed by Macrophage Foam Cells
Proteins differing in relative abundance in the conditioned medium of control and foam cells were identified as described in the legend to Figure 1. A positive or
negative value for the G-test indicates an increased or decreased level of protein expression relative to the control. See also Table S1.
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A Macrophage Sterol-Responsive Network(p = 0.01). Whereas alterations in lipid metabolism are known to
regulate foam cells, the potential roles of the cytoskeleton and
vesicular transport in foam cell formation have received little
attention, though vesicular transport is thought to play a key
role in the intracellular trafficking of lipids.
Third, we used an algorithm to systematically search PubMed
for documented atherosclerotic phenotypes in mice with genetic
manipulations (e.g., targeted mutagenesis, transgenic overex-
pression) of proteins we detected in macrophage-conditioned
media. Remarkably, mice that overexpress or lack any of 10 of
the 46 sterol-responsive proteins have atherosclerotic pheno-
types (Figure 3; indicated by a blue border). In contrast, only
21 of the other 731 proteins detected in macrophage-condi-
tioned media have demonstrated atherogenic phenotypes in
mice (Table S2). This greater than 8-fold enrichment of proteins
associated with atherosclerosis in the sterol-responsive proteins
was highly significant (p = 3 3 106, Fisher’s exact test). More-
over, previous studies have shown that the atherosclerotic
phenotypes of 6 of the 10 sterol-responsive proteins were reca-
pitulated in mice by transplanting bone marrow from genetically
engineered mice into wild-type mice. Thus, macrophage-Cell Mspecific expression of these proteins may contribute to athero-
genesis.
Collectively, these observations identify a set of 46 proteins
that respond to sterol loading ofmacrophages in vivo in a coordi-
nated fashion. We term this set the ‘‘macrophage sterol-respon-
sive network’’ (MSRN) (Figure 3A) because these proteins are: (1)
coordinately regulated when Ldlr/ macrophages become
foam cells in vivo, (2) integrated through predicted protein-
protein interactions, (3) functionally overrepresented in proteins
involved in lipid binding, cytoskeletal regulation, and vesicle-
mediated transport, and (4) highly enriched in proteins with caus-
ative roles in atherogenesis.
Most MSRN Proteins Localize to Vesicles
Shed microvesicles are enriched in cholesterol and proteins that
are involved in vesicular transport and cytoskeletal regulation
(Simpson et al., 2008), and these two functional categories are
significantly enriched in the MSRN. To test the hypothesis that
a subset of MSRN proteins resides in microvesicles, we centri-
fuged macrophage-conditioned medium at 100,000 3 g and
analyzed the pelleted material by LC-ESI-MS/MS. Theetabolism 11, 125–135, February 3, 2010 ª2010 Elsevier Inc. 127
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Figure 3. The Macrophage Sterol-Responsive Network
(A) A protein-protein interaction network was constructed, using the 46 proteins that were differentially expressed (upregulated, red; downregulated, green) by
macrophage foam cells isolated from Ldlr/ mice. GO analysis of the network revealed modules enriched in proteins implicated in lipid binding, cytoskeletal
regulation, and vesicle-mediated transport (p = 0.01, 0.001, and 0.003, respectively; Fisher’s exact test with Benjamini-Hochberg correction). Proteins that asso-
ciate with an atherosclerotic phenotype (circled in blue) in genetically engineered mice or with myeloid-specific expression/deletion as assessed by bonemarrow
transplantation (BMT, **) were identified with PubMatrix. Note that 10 of 16 sterol-responsive proteins that were not previously shown to interact physically or
functionally with other MSRN proteins, termed previously unassigned, reside in the microvesicle fraction.
(B) Comparison of MSRN protein expression in media and isolated microvesicles. A positive or negative value for theG-test indicates an increased or decreased
level of protein expression relative to the control.
See also Table S2.
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A Macrophage Sterol-Responsive Networkmicrovesicle fraction contained 32 of the 46 MSRN proteins
(Table S3). Moreover, 8 of 12 proteins that lacked previously
known binding or functional associations with other MSRN
proteins (Figure 3A) were detected in the pelleted material, sug-
gesting that they were associated with other members of the
MSRN in microvesicles. Remarkably, the relative abundance of
26 of 32 MSRN proteins in the microvesicle fraction changed
significantly in a manner that mirrored that of macrophage-
conditioned medium (Figure 2). These observations strongly
suggest that most sterol-responsive proteins in macrophage-
conditioned medium are physically coassembled into one or
more populations of vesicles. This hypothesis offers a structural
explanation for the MSRN’s enrichment in known physical inter-
actions and functional annotations.
Antiatherosclerotic Interventions Target the MSRN
If the MSRN orchestrates a molecular network involved in
atherogenesis, interventions aimed at treating atherosclerosis
should specifically affect that network. To test this notion, we
harvested macrophages from Ldlr/ mice that had received
100 mg/kg/day simvastatin or 10 mg/kg/day rosiglitazone for
the last 2 weeks of the 14 week western diet. Other investigators
have demonstrated that these interventions retard atheroscle-
rosis in Ldlr/mice without altering levels of circulating lipopro-
teins (Chen et al., 2002; Li et al., 2000).128 Cell Metabolism 11, 125–135, February 3, 2010 ª2010 Elsevier InNeither statin nor rosiglitazone therapy affected plasma
cholesterol levels or plasma lipoprotein profiles (Figure S1), but
they reduced macrophage cholesterol accumulation by 40%
(Figure 4A). In striking contrast, both interventions markedly
altered the expression pattern of MRSN proteins in macro-
phages isolated from Ldlr/ mice. Indeed, only 2 (statin) and
4 (rosiglitazone) of the 46 MSRN proteins were still differentially
expressed by macrophages isolated from Ldlr/ mice that
had received the high-fat diet and one of the two interventions
(Figures 4B and 4C). Neither intervention appreciably altered
levels of non-MSRN proteins in macrophage-conditioned
medium (Figure 4D), indicating that the effect on the MSRN
was specific. These data demonstrate that two different pharma-
cological interventions, each of which inhibits atherosclerosis
without affecting plasma cholesterol levels, specifically target
the MSRN. Thus, dysregulation of this network might promote
the development of atherogenesis in vivo, and pharmacologic
interventions that retard atherosclerosis might act, in part, by
normalizing expression of the MSRN.
Apolipoprotein E Is a Key Protein in the MSRN
Because simvastatin or rosiglitazone therapymarkedly alters the
expression pattern of MSRN proteins in macrophages isolated
from Ldlr/ mice while only modestly affecting macrophage
sterol levels (Figure 4A), cholesterol accumulation alone isc.
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A Macrophage Sterol-Responsive Networkunlikely to explain MSRN regulation. Instead, a protein that inter-
acts with many other proteins might exert widespread effects on
its parent network if its expression changed (Chen et al., 2008).
APOE, which is underexpressed in the MSRN and is highly anti-
atherogenic in mice (Bellosta et al., 1995; Linton et al., 1995),
might be one such protein. To test the proposal that APOE regu-
lates the MSRN, we harvestedmacrophages from Apoe/mice
fed a low-fat or western diet, incubated them for 6 hr, and
analyzed the conditioned media with proteomic methods.
Diet-induced changes in plasma cholesterol and lipoproteins
(Figure S1) were similar in the Apoe/ and Ldlr/ mice. More-
over, > 96% of the proteins detected in media conditioned by
macrophages from the two mouse strains were the same.
Thus, the overall pattern of protein expression was similar in
the two genotypes. In contrast, Apoe/ macrophages isolated
frommice on the western diet displayed significantly higher cho-
lesteryl ester levels than Ldlr/ macrophages (Figure 5A). ThisCell Mobservation is consistent with APOE’s well-established role in
promoting cholesterol efflux from macrophages (Langer et al.,
2000).
Despite this difference in cholesteryl ester content, only six
proteins responded to sterol accumulation in Apoe/ macro-
phages (Table S4; estimated FDR = 6.4%). Moreover, the extent
ofMSRNregulation imposedbycholesterol loadingwassubstan-
tially attenuated in Apoe/mice (compare Figures 5B and 5C).
These observations suggest that macrophages need to
express APOE to modulate MSRN expression in vivo, raising
the possibility that APOE is an important node in the network.
To test this proposal, we compared protein expression levels
in conditioned media of macrophages isolated from Apoe/
and Ldlr/ mice. The expression of many MSRN proteins in
the Apoe/ macrophages from mice on the chow diet strongly
resembled that in Ldlr/ macrophages loaded with cholesteryl
ester (Figure 5D). Thus, levels of 40% of the MSRN proteinsetabolism 11, 125–135, February 3, 2010 ª2010 Elsevier Inc. 129
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Figure 5. Role of APOE in Regulation of the MSRN
Macrophages were isolated from the peritoneum of
Ldlr/ or Apoe/ mice fed a chow or western diet for
14 weeks.
(A) Macrophage cholesterol (MfC) levels. FC, free choles-
terol; CE, cholesteryl ester. Results represent means and
standard deviations.
(B and C) Differential expression of MSRN proteins. Red,
increased protein level; green, decreased protein level.
Proteins are in the same order, top to bottom, as in
Figure 2. (B) Ldlr/ macrophages, chow versus western
diet. (C) Apoe/macrophages, chow versus western diet.
(D) Quantification of MSRN proteins by LC-ESI-MS/MS
and spectral counting of macrophages harvested from
Ldlr/ or Apoe/ mice fed a chow (C) or western (W)
diet for 14 weeks.
(E) Subset of MSRN proteins that are dysregulated in
macrophages harvested from Apoe/ mice fed a low-fat
diet.
(F) Immunoblot analysis of conditioned medium of macro-
phages harvested from C57BL/6J mice and treated with
siRNA to APOE.
See also Figure S3.
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A Macrophage Sterol-Responsive Networkin Ldlr/ foam cells and Apoe/ control cells were statistically
indistinguishable (p > 0.1, two-tailed Student’s t test) (Figure 5E
and Table S5). This suggests that APOE deficiency regulates the
expression—either stimulation or repression—of a subset of
MSRN proteins even in the absence of cholesterol loading.
To further test the hypothesis that APOE regulates the MSRN
in the absence of cholesterol loading, we isolated macrophages
from wild-type C57BL/6J mice. We then acutely lowered the
cells’ APOE level by treating them with siRNA duplexes and
monitored changes in APOE, CTSL, CYSC, and CLTC levels in
the medium. As predicted from the proteomic analysis of
Apoe/ macrophages, immunoblot analysis confirmed that
CTSL and CYSC levels fell when APOE release into medium
was suppressed, whereas the level of CLTC, a protein that was
not regulated by APOE (Table S5), remained unchanged
(Figure 5F). We obtained similar results when we isolatedmacro-
phages from Ldlr/mice, suggesting that LDLR is not an impor-
tant regulator of the MSRN (Figure S2).
These observations provide evidence for coordinate regula-
tion of MSRN proteins. As a further test, we treated peritoneal130 Cell Metabolism 11, 125–135, February 3, 2010 ª2010 Elsevier Inc.macrophages isolated from Ldlr/ mice with
control siRNA duplexes or siRNA duplexes
specific for CTSL, CYSC, or C3. Then, we
used immunoblotting to monitor the expression
of ACTB, APOE, CLTC, CTSL, CYSC, and C3
protein in macrophage-conditioned media
(Figure S3). siRNA-mediated knockdown of
CYSC significantly reduced ACTB (p = 0.02),
CLTC (p = 0.006), and C3 (p = 0.04) levels
without altering APOE or CTSL levels. On the
other hand, downregulation of CTSL lowered
C3 expression (p = 0.04) without affecting
ACTB, APOE, CLTC, or CYSC levels. Finally,
reducing C3 expression elevated APOE levels
(p = 0.05) and lowered CTSL expression
(p = 0.003) but had no effect on ACTB, C3,CLTC, and CYSC levels. Taken together, these studies provide
strong evidence for coordinate regulation of MSRN proteins.
Statins Normalize the MSRN in Ldlr/, but Not Apoe/,
Macrophages
Our observations indicate that APOE is an important regulator of
the MSRN. Moreover, previous studies have demonstrated
that simvastatin retards atherosclerosis in Ldlr/ mice, mice but
not in Apoe/mice (Wang et al., 2002). Thus, antiatherosclerotic
interventions might normalize the network by restoring APOE
levels.
To test this idea, we compared the effects of simvastatin
therapy (100 mg/kg/day for 2 weeks) on the MSRN in macro-
phages isolated from Ldlr/ and Apoe/ mice fed a western
diet. Statin therapy reversed the expression pattern of MSRN
proteins in macrophages isolated from Ldlr/ mice, but not in
those of Apoe/mice (Figures 6A and 6B). This difference could
not be explained by differential cholesterol accumulation
because simvastatin therapy reduced macrophage cholesterol
levels to a similar extent (40%) in both genetic backgrounds
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Figure 6. APOE Expression in Atherosclerotic Lesions of Ldlr/
Mice
Ldlr/ or Apoe/mice were fed a western diet for 14 weeks or a western diet
plus simvastatin (Statin) or rosiglitazone (Rosi) for the final 2 weeks of the
regimen.
(A and B) Differential expression of MSRN proteins by macrophages isolated
from statin-treated Ldlr/ or Apoe/mice fed a western diet. Red, increased
protein level; green, decreased protein level. Proteins are in the same order,
top to bottom, as in Figure 2.
(C) Immunohistochemical staining of aortic sinus sections isolated from Ldlr/
mice on the different regimens. Adjacent sectionswere immunostainedwith anti-
bodies to APOEorMAC2 (amacrophagemarker). *, necrotic core. Images, 103.
Cell Metabolism
A Macrophage Sterol-Responsive Network
Cell M(Figure S4). These findings are consistent with the proposal that
APOE regulates the MSRN to inhibit atherogenesis.
Antiatherosclerotic Interventions Restore Lesion APOE
Expression
Taken together, our data suggest that restoring levels of macro-
phage APOE normalizes the MSRN expression pattern and that
this normalization is a critical component of simvastatin’s action.
We also found that APOE was one of the most strongly downre-
gulated MSRN proteins in cells harvested from Ldlr/ mice fed
a western diet. To explore the possibility that simvastatin and
rosiglitazone inhibit atherosclerosis partly by increasing APOE
levels in artery wall macrophages, we used immunohistochem-
istry to investigate expression of APOE and the macrophage
marker MAC2 in aortic lesions of Ldlr/ mice fed a western
diet for 14 weeks.
The lesions contained high levels of APOE. However, the bulk
of immunoreactive material localized to their necrotic cores
(Figures 6C and S5). Treating the animals for 2 weeks with sim-
vastatin or rosiglitazone markedly increased macrophage
APOE protein levels (simvastatin, p = 0.04; rosiglitazone,
p = 0.03) without appreciably altering the amount of APOE
detected in the necrotic core (Figures 6C, 6D, and S5). Collec-
tively, these observations provide strong evidence that macro-
phage foam cells in the artery wall, like foam cells isolated
from the peritoneal cavity of hypercholesterolemic Ldlr/
mice, have abnormally low APOE levels that are normalized by
antiatherosclerotic interventions.
DISCUSSION
In contrast to traditional biochemical studies that focus on indi-
vidual proteins, our approach seeks to identify protein networks
that coherently respond to environmental, pharmacological, and
genetic interventions that promote cardiovascular disease. We
therefore used tandemmass spectrometry in concert with bioin-
formatics to obtain a comprehensive view of the shed and
secreted proteome of macrophage foam cells generated
in vivo. By determining the known physical interactions and bio-
logical functions of differentially expressed proteins, we identi-
fied themacrophage sterol-responsive network (MSRN), a highly
integrated network of proteins that are coordinately regulated by
sterol loading.
Networks of highly interconnected proteins can develop new,
disease-causing properties when strongly perturbed (Lusis et al.,
2008; Chen et al., 2008), and two lines of evidence suggest that
modulating the expression of key MSRN proteins can influence
atherosclerosis. First, relative to the overall shed and secreted
macrophage proteome, the MSRN was greatly enriched in
proteins linked to established atherosclerotic phenotypes in
transgenic and knockout mice. Moreover, levels of APOE, C3,
CYSC, LRP1, LYZ, and MFGE8 were lower when macrophages
were loaded with sterol in vivo, and atherosclerosis is enhanced
in mice that lack any of those proteins (Bellosta et al., 1995;(D) Quantification of immunohistochemical staining for APOEandMAC2. Results
(n = 5 per group) are means and standard deviations.
See also Figure S5.
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Overton et al., 2007; Liu et al., 2006; Ait-Oufella et al., 2007). In
contrast, ADFP levels were enhanced in cholesterol-loaded
macrophages, and transgenic expression of ADFP promotes
atherosclerosis in mice (Paul et al., 2008). These observations
further support our proposal that MSRN proteins are coordi-
nately regulated and that network dysregulation is important
for foam cell formation and atherogenesis.
Second, treating Ldlr/micewith rosiglitazone, which retards
atherosclerosis without affecting plasma cholesterol levels in this
genetic background (Li et al., 2000), reversed the protein expres-
sion pattern that is seen when macrophages are loaded with
sterol in vivo. We observed a similar reversal in macrophages
isolated from statin-treated Ldlr/ mice, but not in macro-
phages isolated from statin-treated Apoe/ mice. Importantly,
statins are known to inhibit atherosclerosis in Ldlr/ mice, but
not Apoe/ mice (Wang et al., 2002). Thus, our results with
two different pharmacological interventions in two different
genetic backgrounds support a model in which sterol-respon-
sive proteins in macrophages form a highly interconnected
network, the MSRN, that promotes atherosclerosis when
dysregulated.
APOE, which plays a key role in macrophage cholesterol
homeostasis, is a particularly striking example of an MSRN
protein. When this protein is missing from macrophages, mice
suffer from accelerated atherosclerosis (Bellosta et al., 1995;
Linton et al., 1995). Classical studies of cultured macrophages
have demonstrated that APOE secretion is upregulated by sterol
loading with acetyl-LDL (Brown and Goldstein, 1983). In
contrast, we found that APOE was one of the most downregu-
lated proteins in the MSRN of macrophage foam cells harvested
from the peritoneum. However, APOE expression increased
markedly when we incubated cultured peritoneal macrophages
of Ldlr/ mice with acetyl-LDL (Figure S6). Other investigators
have also noted significant differences in the expression patterns
of cultured macrophages and foam cells generated in vivo. For
example, Li et al. found that PPARa, PPARb, and PPARg
agonists induced cultured macrophages to express ABCA1
and LXRa (Li et al., 2000). In striking contrast, all three agonists
failed to influence the expression of those genes in atheroscle-
rotic lesions or in foam cells derived from hypercholesterolemic
mice. These observations support the proposal that macro-
phages of Ldr/ mice loaded with cholesteryl ester in vivo
provide a relevant model for studying foam cells’ roles in
atherosclerosis.
Because APOE is one of the most downregulated MSRN
proteins, statins and thiazolidinediones might inhibit atherogen-
esis, in part, by increasing APOE expression by artery wall
macrophages. Indeed, in immunohistochemical studies of
Ldlr/ mice fed a western diet, APOE was readily visualized in
the acellular necrotic core of atherosclerotic lesions but was
essentially undetectable in macrophages. In contrast, it was
readily detectable in both locations in statin- or rosiglitazone-
treated animals. These results imply that the APOE levels are
likely to be diminished in artery wall foam cells of hypercholester-
olemic Ldlr/mice and that this effect is partly reversed by sta-
tin or rosiglitazone treatment. Thus, our observations support the
proposal that pharmacological interventions target the MSRN in
Ldlr/ mice and that the ability to regulate the network is one132 Cell Metabolism 11, 125–135, February 3, 2010 ª2010 Elsevier Inatheroprotective effect of statin and rosiglitazone in this model
of hypercholesterolemia.
Unexpectedly, we found that expression of one-third of the
MSRN proteins was dysregulated in macrophages isolated
from Apoe/ mice on the low-fat diet. These cells showed little
evidence of sterol accumulation, implying that APOE modulates
the expression of a subset of MSRN proteins and that the
network is dysfunctional in macrophages lacking APOE. Genetic
ablation of other highly interconnected proteins within theMSRN
might similarly potentiate network dysregulation and atherogen-
esis. This hypothesis is strengthened by the demonstration that
mice deficient in ADFP (Paul et al., 2008), APOE (Bellosta et al.,
1995), LPL (Babaev et al., 2000), LRP1 (Overton et al., 2007), LYZ
(Liu et al., 2006), or MFGE8 (Ait-Oufella et al., 2007), all of
which map to the network, have macrophage-specific pheno-
types. Moreover, we found that attenuating levels of individual
proteins in the MSRN with siRNA affected the expression of
other network proteins.
Proteins involved in lipid binding, cytoskeletal regulation, and
vesicle-mediated transport were overrepresented in the MSRN,
and mice lacking proteins implicated in those functions have
atherosclerotic phenotypes (Buono et al., 2002; Overton et al.,
2007; Ait-Oufella et al., 2007; Feil et al., 2004). The network
was also greatly enriched in proteins with known physical inter-
actions, raising the possibility that macromolecular assemblies
might partly account for the link between sterol-responsive
proteins and functional categories. Remarkably, when macro-
phage-conditioned medium was centrifuged at 100,000 3 g,
more than two-thirds of the MSRN proteins localized to the
pellet, indicating that they likely resided in the microvesicle frac-
tion. Colocalization in microvesicles, which transfer proteins and
RNA between neighboring cells and have been implicated in
thrombosis, cytokine release, and inflammation (Cocucci et al.,
2009), would readily account for the enrichment of physical
and functional interactions that we observed in MSRN proteins.
We therefore propose that the atherogenic actions of choles-
terol-loadedmacrophages are an emergent property that results
when the normal balance of MSRN proteins in microvesicles is
perturbed. We further suggest that certain dietary factors or
genetic variations can disturb this network, thereby promoting
vascular disease. By integrating mouse and human data, we
hope to better understand the MSRN’s role in foam cell forma-
tion, with the long-term goal of identifying therapeutic interven-
tions for targeting networks rather than individual proteins.EXPERIMENTAL PROCEDURES
Macrophage Foam Cell Formation
Male Ldlr/ andApoe/mice on the C57BL/6J genetic background received
a chow (4% fat [w/w]; PicoLab, Rodent diet 20:50503) or western diet (21%
fat, 1.25% cholesterol; Harlan Teklad, #TD96121) for 14 weeks. For antiather-
osclerotic interventions, animals were fed the western diet to which simvasta-
tin (100 mg/kg/day; Merck & Co Inc.) or rosiglitazone (10 mg/kg/day;
GlaxoSmithKline) were added during the last 2 weeks of the diet. Four inde-
pendent biological replicates were obtained for each experimental condition.
Peritoneal macrophages were harvested from the mice 5 days after thioglyco-
late was injected. Cells were washed with phosphate-buffered saline (PBS),
seeded into T-75 flasks (20 3 106/flask), incubated at 37C for 2 hr in
serum-free Dulbecco’s minimum essential medium (DMEM), and washed
three times with PBS. Macrophages were then cultured for 6 hr in DMEM.c.
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Macrophage-conditioned medium (10 mg protein/ml) was collected, clarified
by centrifugation (5 min at 10003 g), supplemented with 0.02% sodium deox-
ycholate and 20% trichloroacetic acid, and incubated overnight at 4C.
Proteins were harvested by centrifugation (15,000 3 g for 30 min at 4C).
The protein pellet was washed twice with ice-cold acetone, reconstituted in
digestion buffer (0.1% Rapigest [Waters Corp.], 50 mM Tris-HCl [pH 8.8]),
and then reduced, alkylated, and digested overnight at 37C with sequencing
grade trypsin (1:50, w/w, trypsin/protein; Promega). Tryptic digests were
mixed with acetic acid (1:1, v/v) and subjected to solid-phase extraction on
a C18 column (HLB, 1 ml; Waters Corp.) according to the manufacturer’s
protocol. Fractions containing peptides were dried under vacuum and resus-
pended in 0.3% acetic acid/5% acetonitrile (1 mg protein/ml) for analysis.Liquid Chromatography-Electrospray Ionization-Tandem MS
Tryptic digests (2 mg protein) were injected in duplicate into a trap column
(Paradigm Platinum Peptide Nanotrap, 0.153 50 mm; Michrom Bioresources,
Inc.) and desalted for 5 min with 5% acetonitrile, 0.1% formic acid (50 ml/min).
Peptides were then eluted onto an analytical reverse-phase column (0.150 3
150 mm, 5 mm beads; Magic C18AQ, Michrom Bioresources, Inc.) and sepa-
rated at a flow rate of 1 ml/min over 180 min, using a linear gradient of 5% to
35% buffer B (90% acetonitrile, 0.1% formic acid) in buffer A (5% acetonitrile,
0.1% formic acid). Mass spectra were acquired in the positive ion mode,
using electrospray ionization and a linear ion trap mass spectrometer
(LTQ, Thermo Electron Corp.) with data-dependent acquisition (Vaisar et al.,
2007). MS/MS scans were obtained on the eight most abundant peaks in
each survey MS scan.Peptide and Protein Identification
MS/MS spectra were searched against the mouse International Protein Index
(IPI) database (version 2006/04/18) (Kersey et al., 2004), using the SEQUEST
search engine with the following search parameters: unrestricted enzyme
specificity, 2.8 amu precursor ion mass tolerance, 1.0 amu fragment ion
mass tolerance, fixed Cys alkylation, and variable Met oxidation. SEQUEST
results were further validated with PeptideProphet (Keller et al., 2002) and Pro-
teinProphet (Nesvizhskii et al., 2003), using an adjusted probability ofR 0.90
for peptides andR 0.96 for proteins. Proteins considered for analysis had to
be identified in every biological replicate of at least one biological condition.
When MS/MS spectra could not differentiate between protein isoforms, all
isoforms were included in the analysis.Protein Quantification
Proteins detected by liquid chromatography-electrospray ionization-tandem
MS (LC-ESI-MS/MS)were quantified by spectral counting (the total number
of MS/MS spectra detected for a protein). Two replicate injections for each
sample were averaged to obtain spectral counts.Microvesicles
Microvesicles were isolated from macrophage-conditioned medium, using
differential centrifugation (Hegmans et al., 2004). Conditioned medium was
precleared by centrifugation at 1000 3 g for 10 min, two spins at 4000 3 g
for 10 min, and one spin at 10,0003 g for 30 min. Microvesicles were isolated
from the supernatant by ultracentrifugation (two 100,000 3 g spins for 1 hr).
The protein pellet was washed with PBS after each spin. Microvesicles were
reconstituted in digestion buffer (0.1% Rapigest [Waters Corp.], 50 mM Tris-
HCl [pH 8.8]), digested with trypsin, and analyzed with MS/MS. Results are
the average of duplicate analyses of four pooled microvesicle isolations for
each condition. Differences in spectral counts between the conditions were
assessed with the G-test (Sokal and Rohlf, 1995).Biochemical Assays
Cholesterol levels were determined using cholesterol oxidase and a fluores-
cence-based peroxidase assay (Invitrogen). Protein concentration of macro-
phage-conditioned medium was determined by the Bradford assay, with
albumin as the standard.Cell MsiRNA
Adhesion-purified peritoneal macrophages from wild-type C57BL/6J mice
were transfected with control siRNA (30 nM, Ambion) or two siRNAs specific
for APOE (30 nM, Ambion) using the DeliverX Plus siRNA transfection kit
(Panomics). Cells were washed three times with PBS and incubated in
serum-free DMEM for 24 hr. Macrophage-conditioned medium was then
collected, and levels of APOE, CTSL, CYSC, and CLTC were quantified by
immunoblot analysis.
Immunoblot Analysis
Macrophage-conditioned medium was subjected to SDS-PAGE on 4%–12%
gradient gels, transferred to PVDF membranes, and probed with antibodies
(0.5 mg/ml) raised against murine ACTB (Abcam), ADFP (Abcam), APOE (Ab-
cam), C3 (Abcam), CTSL (R&D Systems), CYSC (Abcam), and LRP1 (Abcam).
Proteins were quantified by densitometry, using Quantity One software
(Biorad).
Analysis of Atherosclerotic Lesions
For immunocytochemical staining, deparaffinized sections from lesions in the
aortic sinus were rinsed in PBS, incubated for 10 min in Peroxo-Block (Zymed
Laboratories Inc., San Francisco, California, USA), and boiled for 10 min in
0.01 M citrate buffer (pH 6.0). Adjacent sections were incubated overnight at
4C with rat anti-MAC2 (Cedarlane, 1:2000) or rabbit anti-APOE (Abcam,
1:500) antibody in PBS containing 1% BSA. Antibodies were detected with
a peroxidase-chromagen system (Dako NovaRed) in sections counterstained
with hematoxylin and eosin. APOE and MAC2 immunoreactivity were quanti-
fied in lesions using Image Pro Plus (Media Cybernetics).
Functional Annotation
Functional enrichments in gene ontology annotations in the MSRN, relative to
the mouse genome, were identified using the Bingo 2.0 plug-in in Cytoscape
(V2.5.2) (Maere et al., 2005). Statistical significance was assessed using the
Fisher’s exact test with Benjamini-Hochberg false discovery rate correction
(Benjamini and Hochberg, 1995). To identify macrophage proteins associated
with an atherosclerotic phenotype in mice, we conducted keyword searches,
using PubMatrix (Becker et al., 2003). The search term was ‘‘protein name,’’
and the modifier terms were ‘‘atherosclerosis and knockout,’’ ‘‘atherosclerosis
and deficiency,’’ and ‘‘atherosclerosis and expression.’’ All positive results
were verified by manual inspection.
Protein Interaction Networks
Protein interaction networks were established from amanually compiled data-
base based on > 200,000 full-text, peer-reviewed articles with Ingenuity
Systems (Calvano et al., 2005). Interactions were validated using the BIND,
DIP, MIPS, IntAct, BioGRID, and MINT databases.
Statistical Analysis
Spectral count differences between foam cells and control cells were as-
sessed using a two-tailed Student’s t test and the G-test (Old et al., 2005).
The G-test evaluates the null hypothesis that observed values are due to
random sampling from a distribution with a given expected value, using an
approximation of the c2 distribution with one degree of freedom. Permutation
analysis was used to empirically estimate the false positive rate. The false
discovery rate, FDR, was estimated as the ratio of the false positive rate to
that of the sum of the false and true positive rates (Benjamini and Hochberg,
1995). Significance cutoff values for the G-statistic and t test were determined
by minimizing the empirical FDR and maximizing the number of differentially
expressed proteins.
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